Peter Wenaweser

Showing 1-20 of 28 articles

Interventions for valvular disease

Left ventricular afterload reduction by transcatheter aortic valve implantation in severe aortic stenosis and its prompt effects on comprehensive coronary haemodynamics

Stoller M, Gloekler S, Zbinden R, Tueller D, Eberli F, Windecker S, Wenaweser P, Seiler C

June 20, 2018 | 10.4244/EIJ-D-17-00719

Coronary interventions

Switzerland: coronary and structural heart interventions from 2010 to 2015

Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Rothlisberger C, Corti R, Rickli H, Kaiser C, Roffi M

May 15, 2017 | 10.4244/EIJ-D-16-00828

Interventions for valvular disease

Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis

Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Jüni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M

April 7, 2017 | 10.4244/EIJ-D-16-00677

Coronary interventions

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S

December 9, 2016 | 10.4244/EIJY15M12_09

Interventions for valvular disease

Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve

Wenaweser P, Stortecky S, Schütz T, Praz F, Gloekler S, Windecker S, Elsasser A

May 16, 2016 | 10.4244/EIJV12I1A13

Interventions for valvular disease

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation

Pilgrim T, Räber L, Limacher A, Wenaweser P, Cook S, Stauffer J-C, Garachemani A, Moschovitis A, Meier B, Jüni P, Windecker S

March 20, 2015 | 10.4244/EIJY15M01_04

Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation

O’Sullivan C, Stortecky S, Heg D, Jüni P, Windecker S, Wenaweser P

February 20, 2015 | 10.4244/EIJV10I10A200

Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry

Wenaweser P, Stortecky S, Heg D, Tueller D, Nietlispach F, Falk V, Pedrazzini G, Jeger R, Reuthebuch O, Carrel T, Räber L, Amann F, Ferrari E, Toggweiler S, Noble S, Roffi M, Gruenenfelder J, Jüni P, Windecker S, Huber C

December 22, 2014 | 10.4244/EIJV10I8A166

Low-flow, low-gradient aortic stenosis: should TAVI be the default therapeutic option?

O’Sullivan C, Wenaweser P

November 20, 2014 | 10.4244/EIJV10I7A134

Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement

Buellesfeld L, Stortecky S, Heg D, Gloekler S, Meier B, Wenaweser P, Windecker S

October 20, 2014 | 10.4244/EIJV10I6A126

Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making

O’Sullivan C, Praz F, Stortecky S, Windecker S, Wenaweser P

September 27, 2014 | 10.4244/EIJV10SUA9

Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat

Stefanini GG, Stortecky S, Wenaweser P, Windecker S

September 27, 2014 | 10.4244/EIJV10SUA10

Accuracy and reproducibility of aortic annulus sizing using a dedicated three-dimensional computed tomography reconstruction tool in patients evaluated for transcatheter aortic valve replacement

Stortecky S, Heg D, Gloekler S, Wenaweser P, Windecker S, Buellesfeld L

July 21, 2014 | 10.4244/EIJV10I3A59

Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents

O’Sullivan C, Stefanini GG, Räber L, Heg D, Taniwaki M, Kalesan B, Pilgrim T, Zanchin T, Moschovitis A, Büllesfeld L, Khattab A, Meier B, Wenaweser P, Jüni P, Windecker S

January 20, 2014 | 10.4244/EIJV9I9A182

Transcatheter aortic valve implantation: the transfemoral access route is the default access

Stortecky S, O’Sullivan C, Buellesfeld L, Windecker S, Wenaweser P

September 15, 2013 | 10.4244/EIJV9SSA4

Severe aortic stenosis and coronary artery disease

Stefanini GG, Stortecky S, Meier B, Windecker S, Wenaweser P

September 15, 2013 | 10.4244/EIJV9SSA12

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Gilard M, Witkowski A, Danenberg H, Schröder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L

April 19, 2013 | 10.4244/EIJV8I12A209

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents

Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini GG, Räber L, Meier B, Jüni P, Windecker S

January 18, 2013 | 10.4244/EIJV8I9A163

Transcatheter aortic valve implantation and cerebrovascular accidents

Stortecky S, Wenaweser P, Windecker S

September 30, 2012 | 10.4244/EIJV8SQA11

Latest news

New issue

Discover the Special Edition on valvular heart disease prepared for PCR London Valves

(3D-TEE model - Optimal implantation)

November 15, 2019

Editorial

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

JAA

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

Trials Book

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

JAA

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Peter Wenaweser

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke